Topic Archives: Intel (INTC)

Today’s teaser ad that we’ll be feeding to the Thinkolator is for Bill Poulos’ Premium Income Alert ($1,997/year) from Profits Run, and it’s a doozy, funneling two hype-filled trends into one stock idea. Premium Income Alert is not a service we’ve looked at before, but it’s billed as a “weekly trading service” (the “upgrade” option […]

This article was originally published on Halloween, 2018, but we’re getting a ton of new questions about it so they must be running the ad heavily again. The ad has NOT been updated in any meaningful way, but some significant things have changed for this stock over the past year (though the stock price is […]

I haven’t written about this particular ad, but I have seen it circulating over the past couple months… and the questions keep rolling in, so I guess the ad’s still in pretty heavy rotation and it’s time to get some answers for you. The pitch is for Jeff Brown’s The Near Future Report ($99/yr “on […]

This is the headline that got a lot of readers’ attention: “WARNING: Do not put a penny into any cryptocurrency until you read this urgent message.” It’s part of an ad for Louis Navellier’s Blue Chip Growth, and he goes on… “If you want to make a fortune in the red-hot cryptocurrency markets, there’s only […]

This is shaping up to be “bitcoin week” here at Stock Gumshoe — I wrote a bit more about my (befuddled and pessimistic) opinion about bitcoin itself late last week, and we got things rolling on Monday with David Gardner’s “bitcoin backdoor” stock… … and today, we move on to Jeff Brown at Bonner and […]

I’m always interested to see what kind of big-growth ideas are being teased, particularly in a market that already feels so expensive, so a Cabot pitch caught my eye again this week — this time it’s from Mike Cintolo for Cabot Growth Investor, and this is what grabbed my attention: “My Expectation: A 25% Jump […]

This article originally appeared as part of the Friday File for the Stock Gumshoe Irregulars (our paid members) on November 20, 2015. The article has not been updated or revised, other than a couple quick updates to numbers and valuations, but we’ve had questions about the ad of late, so we’re moving it back to […]

It’s like the Stansberry folks know what appeals to your friendly neighborhood Stock Gumshoe… and they just can’t get enough of our coverage. Every time I turn around lately they’re teasing and promoting a different kind of “royalty” company. And I loves me some royalties. Royalty companies are pretty well understood by most investors — […]

This is a note of little consequence, but I’ve promised to share my portfolio when it comes to equity trades so I thought I should let you know that I sold the vast majority of my Intel (INTC) shares over the weekend. Not because I particularly wanted to sell, but because I had sold covered […]

Sometimes I look back and realize I’ve been a dope. This is one of those times. I’ve been holding and/or actively buying shares of stocks that benefit from the mobile revolution and from the massive consumer businesses the breakthrough products from Apple (iPhone and iPad) have essentially created from scratch over the last couple years […]

This week, in an effort to be as boring as possible, I picked up small positions in two technology dinosaurs who are likely to pay growing dividends — Cisco (CSCO) and Intel (INTC). Both companies face strong competition and some specific challenges — most prominently Intel with their challenges in building an effective mobile chip […]

Comments

  • Travis Johnson, Stock Gumshoe

    We keep seeing this ad and getting more questions about it -- the ad hasn't changed in any big way that I've noticed, th...

  • Avatar

    I've often wondered how companies that develop something that eliminates disease, such as this, will make money. The OUT...

  • Avatar

    $12 trillion? That's over half of the US economy. Even over 10 years, it's never going to happen. I guess for $79/yea...

  • Avatar

    Well I just hope this is a boomer like the "God Key" stocks (EDIT, CRSP) which are about 50% lower from their peaks in 2...

  • Avatar

    Although the last three months is a short time period, it's the only one I could research easily. Over that period, the...

  • Avatar

    I think its cell data. https://www.investors.com/news/technology/crispr-gene-editing-biotech-companies/ https://mo...

  • Avatar

    There've been a lot of uncertainties around the CRISPR companies, but I think right now the elephant in the room is the ...

  • Avatar

    Found the article I remember that talks about the patent license. https://www.forbes.com/sites/matthewherper/2015/08/10/...

  • Avatar

    Amazing how they can predict uranium demand (prices) over the next 15 years or more. After you've spent about $75,000-$...

  • Avatar

    Thanks for putting everything into perspective. I read about "exciting new developments" every day, and it is impossibl...

  • Avatar

    I bought CRSP and I am up over 60%. Might think about the other two as well. This technology will take some time to deve...

  • Avatar

    I gave up on EDIT, NTLA, and CRSP and went with Illumina, Inc. (ILMN) which is similar but much less volatile. And ILMN ...

  • Avatar

    If you read all the way down to the end of Altucher's epic screed you see that he says you should buy all three: EDIT, N...

  • Travis Johnson, Stock Gumshoe

    I have a really hard time with R&D companies or very early-stage clinical biotechs -- partly because it's an end market ...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info